Acorda Therapeutics
ACOR
#10357
Rank
โ‚ฌ0.72 M
Marketcap
0,58ย โ‚ฌ
Share price
0.00%
Change (1 day)
-95.89%
Change (1 year)

EPS for Acorda Therapeutics (ACOR)

EPS in 2023 (TTM): -9,87ย โ‚ฌ

According to Acorda Therapeutics 's latest financial reports the company's current EPS (TTM) is -8,60ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -77,57ย โ‚ฌ an increase over its 2021 EPS that were of -175,55ย โ‚ฌ.

EPS history for Acorda Therapeutics from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-9,87ย โ‚ฌ-87.28%
2022-77,57ย โ‚ฌ-55.81%
2021-175,55ย โ‚ฌ-16.13%
2020-209,32ย โ‚ฌ-65.51%
2019-606,85ย โ‚ฌ-898.61%
201875,99ย โ‚ฌ-114.88%
2017-510,81ย โ‚ฌ536.84%
2016-80,21ย โ‚ฌ-392.31%
201527,44ย โ‚ฌ-39.53%
201445,38ย โ‚ฌ4.88%
201343,27ย โ‚ฌ-89.54%
2012413,72ย โ‚ฌ409.09%
201181,27ย โ‚ฌ-333.33%
2010-34,83ย โ‚ฌ-85.14%
2009-234,30ย โ‚ฌ1.37%
2008-231,13ย โ‚ฌ51.03%
2007-153,03ย โ‚ฌ-68.27%
2006-482,32ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
1,84ย โ‚ฌ-121.38%๐Ÿ‡บ๐Ÿ‡ธ USA
0,68ย โ‚ฌ-107.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,69ย โ‚ฌ-91.92%๐Ÿ‡ฉ๐Ÿ‡ช Germany
-6,89ย โ‚ฌ-19.92%๐Ÿ‡บ๐Ÿ‡ธ USA